The present invention relates to novel 5-pyrimidinecarboxamide derivatives
and the pharmaceutical compositions containing said derivatives, and more
specifically, to 5-pyrimidinecarboxamide derivatives and their
pharmacutically able salts, the process for preparing them, and the
pharmaceutical compositions containing said compounds as active
ingredients. In particular, said 5-pyrimidinecarboxamide derivatives of
the present invention, due to their inhibitory activity against the
proliferation of human immunodeficiency virus (HIV) as well as hepatitis B
virus (HBV), can be used as a therapeutic agent as well as a preventive
agent for hepatitis B and acquired immune deficiency syndrome (AIDS).
A invenção atual relaciona-se aos derivatives da novela 5-pyrimidinecarboxamide e as composições pharmaceutical que contêm derivatives ditos, e mais especificamente, aos derivatives 5-pyrimidinecarboxamide e seus sais pharmacutically capazes, o processo para prepará-los, e as composições pharmaceutical que contêm compostos ditos como ingredientes ativos. Em particular, disse os derivatives 5-pyrimidinecarboxamide da invenção atual, devido a sua atividade inhibitory de encontro ao proliferation do vírus humano do immunodeficiency (HIV) as.well.as o vírus do hepatitis B (HBV), pode ser usado como um agente therapeutic as.well.as um agente preventivo para o hepatitis B e o syndrome imune adquirido da deficiência (AIDS).
